Healthcare -
Biotechnology - NASDAQ - US
$ 2.95
-10.3 %
$ 2.15 B
Market Cap
-3.28
P/E
IBRX - NET CHANGE IN CASH
Net Change in Cash IBRX - ImmunityBio, Inc.
161 M
LAST VALUE
4.89%
2 YEAR CAGR
90.07%
5 YEAR CAGR
92.18%
10 YEAR CAGR